Table 5.
Multivariate linear regression analysis to evaluate the relation between severity of disease parameters and treatment and mortality (34 events)
| Variable | OR estimate 95%CI | P–value |
|---|---|---|
| Model 1 | ||
| Age | 1.043 (0-997–1.097) | 0.08 |
| Oxygen therapy on diagnosis | 5.386 (2.057–15.35) | <0.001 |
| Lymphocytes | 0.195 (0.049–0.625) | 0.01 |
| CRP | 1.005 (1.001–1.012) | 0.07 |
| AZT/HCQ combination | 0.578 (0.208–1.536) | 0.28 |
| Model 2 | ||
| Age | 1.041 (1.001–1.089) | 0.07 |
| Congestive heart failure (LVEF < 45%) | 1.222 (0.309–4.649) | 0.77 |
| Atrial fibrillation | 1.406 (0.519–3.707) | 0.49 |
| Peripheral vascular disease | 2.905 (1.088–7.928) | 0.03 |
| ARBs (current medication) | 0.093 (0.005–0.540) | 0.03 |
LVEF, left ventricular ejection fraction.